1-Day Conference

Medical Update: Clinical Practice

A focused clinical update on cardiometabolic disease, obesity, gastrointestinal conditions, cancer screening, and sleep medicine for everyday practice.

cardiometabolic riskobesity managementcancer screeningsleep medicinepreventive care
  • 7:00 AM – 11:45 AM

    Schedule

  • 16 Modules

    Workshops

  • Online Course

    Format

  • 1 Day

    Duration

About this Conference

This conference delivers an integrated clinical update on hypertension, lipids, obesity, gastrointestinal disease, cancer screening, and sleep medicine. Learners will review high-yield guidelines, apply practical treatment algorithms, and refine their approach to common complaints seen in primary care and general medical practice. The emphasis is on translating current evidence into efficient, patient-centered care at the bedside and in the clinic.

Key Objectives

What you'll learn and be able to apply after completing this conference.

Apply current evidence to manage hypertension, dyslipidemia, and global cardiovascular risk across diverse adult patients.

Integrate lifestyle and pharmacologic strategies, including anti-obesity medications and GLP-1–based therapies, into obesity care.

Optimize evaluation and management of common gastrointestinal, cancer screening, and sleep-related complaints in outpatient practice.

Conference Outline

1-day schedule with 16 workshops.

Day 1

7:00 AM11:45 AM

1

Hypertension, Lipids, and Global Cardiovascular Risk

Integrated approach to assessing and treating hypertension and dyslipidemia while estimating and lowering overall cardiovascular risk.

7:00 AM8:00 AM 60 min

  • Use contemporary cardiovascular risk assessment tools to guide blood pressure and lipid targets.
  • Select evidence-based antihypertensive and lipid-lowering regimens tailored to individual patient risk.
  • Identify patients with resistant or secondary hypertension who require further workup or referral.
Risk Assessment and Blood Pressure Targets in Clinical Practice

Review cardiovascular risk calculators, blood pressure classifications, and target-setting strategies for everyday care.

7:00 AM 15 min
hypertensioncardiovascular riskrisk stratification
Managing Primary Hypertension and Combination Therapy

Practical strategies for stepwise pharmacologic treatment of primary hypertension, including use of combination therapy.

7:15 AM 15 min
hypertension managementantihypertensive agentstreatment algorithms
Resistant and Secondary Hypertension: When to Investigate and Refer

Recognizing resistant and secondary hypertension and choosing appropriate diagnostic and referral pathways.

7:30 AM 15 min
resistant hypertensionsecondary hypertensionreferral criteria
Lipid Management and ASCVD Prevention Across Risk Groups

Evidence-based approach to statins, nonstatin therapies, and ASCVD prevention for primary and secondary prevention populations.

7:45 AM 15 min
dyslipidemiastatinsascvd prevention
Break
2

Obesity and Weight Management in the Era of GLP-1–Based Therapies

Comprehensive approach to lifestyle, pharmacologic, and GLP-1–based treatments for obesity in clinical practice.

8:15 AM9:15 AM 60 min

  • Assess obesity-related risk and readiness for change using structured tools.
  • Differentiate among lifestyle, pharmacologic, and procedural options for obesity management.
  • Implement safe prescribing, monitoring, and follow-up plans for GLP-1–based obesity therapies.
Foundations of Lifestyle and Behavioral Treatment for Obesity

Key elements of nutrition, physical activity, and behavioral counseling for long-term weight management.

8:15 AM 15 min
lifestyle interventionsobesity managementnutrition counseling
Patient Selection and Shared Decision-Making for Anti-Obesity Medications

Determining who is an appropriate candidate for anti-obesity medications and engaging patients in shared decisions.

8:30 AM 15 min
obesity pharmacotherapyshared decision makingrisk benefit assessment
Practical Use of GLP-1–Based Therapies in Obesity Care

Dosing, titration, monitoring, and adverse effect management for GLP-1–based therapies used in obesity.

8:45 AM 15 min
glp1 receptor agonistsobesity treatmentmedication monitoring
Long-Term Follow-Up, Weight Maintenance, and Special Populations

Strategies for maintaining weight loss, addressing weight regain, and individualizing care for special populations.

9:00 AM 15 min
chronic disease managementobesity complicationsspecial populations
Break
3

GI and Cancer Screening Update: From GERD to Colorectal Cancer

Evidence-based management of GERD and dyspepsia and practical approaches to colorectal cancer screening and surveillance.

9:30 AM10:30 AM 60 min

  • Differentiate uncomplicated GERD from presentations that warrant further investigation.
  • Select appropriate colorectal cancer screening modalities for average- and high-risk patients.
  • Plan surveillance intervals after polypectomy based on guideline-directed risk stratification.
Evaluation and Initial Management of GERD in Primary Care

Recognizing typical and atypical GERD presentations and choosing initial empiric therapies.

9:30 AM 15 min
gerddyspepsiaprimary care
Alarm Features, Endoscopy, and Barrett Esophagus

Identifying alarm features, indications for endoscopy, and management implications of Barrett esophagus.

9:45 AM 15 min
upper endoscopybarrett esophagusalarm symptoms
Colorectal Cancer Screening Modalities and Risk Stratification

Comparing stool-based tests, sigmoidoscopy, colonoscopy, and other options for colorectal cancer screening.

10:00 AM 15 min
colorectal cancer screeningscreening guidelinesrisk stratification
Post-Polypectomy Surveillance and Communication of Results

Determining surveillance intervals after polypectomy and closing the loop on results with patients.

10:15 AM 15 min
post polypectomy surveillancefollow up carepatient communication
Break
4

Sleep, Brain Health, and Metabolic Disease

Connections between sleep, cognition, mood, cardiometabolic risk, and practical approaches to common sleep complaints.

10:45 AM11:45 AM 60 min

  • Screen for common sleep disorders using brief, validated tools.
  • Recognize the impact of sleep disorders on cardiometabolic and neuropsychiatric outcomes.
  • Select appropriate nonpharmacologic and pharmacologic treatments for insomnia and related conditions.
Recognizing Sleep Disorders in the Outpatient Visit

Identifying insomnia, circadian rhythm disorders, and other sleep problems in busy clinical encounters.

10:45 AM 15 min
sleep disordersscreening toolsoutpatient care
Obstructive Sleep Apnea, Cardiometabolic Risk, and Referral Pathways

Understanding when to suspect obstructive sleep apnea, order testing, and collaborate with sleep specialists.

11:00 AM 15 min
obstructive sleep apneacardiometabolic riskreferral management
Sleep, Cognition, and Mood: Implications for Clinical Practice

How sleep disturbance intersects with cognitive complaints, depression, and anxiety in adult patients.

11:15 AM 15 min
sleep deprivationcognitive impairmentmood disorders
Nonpharmacologic and Pharmacologic Approaches to Insomnia

Combining sleep hygiene, CBT-I principles, and judicious use of medications for insomnia.

11:30 AM 15 min
insomniabehavioral therapysleep medicines
End of Day

Start learning today.

Join this conference to access all modules, earn your certificate, and advance your career.